Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity

JAMA Oncol. 2021 Oct 1;7(10):1578-1579. doi: 10.1001/jamaoncol.2021.3341.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Medical Oncology
  • Medical Writing*
  • Neoplasms* / drug therapy
  • Precision Medicine
  • Randomized Controlled Trials as Topic